Amplitude for A/L = 0.338. by Muhammad Hammad Bucha (21736111)

“…Increased surface roughness significantly reduced power output, flapping frequency, and amplitude. …”

Parameters of energy harvesting. by Muhammad Hammad Bucha (21736111)

“…Increased surface roughness significantly reduced power output, flapping frequency, and amplitude. …”

Graph for Max Amplitude/Length at G_y = 0. by Muhammad Hammad Bucha (21736111)

“…Increased surface roughness significantly reduced power output, flapping frequency, and amplitude. …”

Amplitude for A/L = 0.02. by Muhammad Hammad Bucha (21736111)

“…Increased surface roughness significantly reduced power output, flapping frequency, and amplitude. …”

Graph for maximum Frequency at G_y = 0. by Muhammad Hammad Bucha (21736111)

“…Increased surface roughness significantly reduced power output, flapping frequency, and amplitude. …”

Graph for maximum Power at G_y = 0. by Muhammad Hammad Bucha (21736111)

“…Increased surface roughness significantly reduced power output, flapping frequency, and amplitude. …”

Amplitude for A/L = 0.03. by Muhammad Hammad Bucha (21736111)

“…Increased surface roughness significantly reduced power output, flapping frequency, and amplitude. …”

Summary of experimentation results. by Muhammad Hammad Bucha (21736111)

“…Increased surface roughness significantly reduced power output, flapping frequency, and amplitude. …”

Piezoelectric eel. by Muhammad Hammad Bucha (21736111)

“…Increased surface roughness significantly reduced power output, flapping frequency, and amplitude. …”

Representative Western blots for proteins from specific gene groups, nitric oxide production, and NETs formation. by Daniel R. Ambruso (12042605)

Neutrophil function assays completed on CGD patients off and after the 4^th dose of IFN-γ. by Daniel R. Ambruso (12042605)

“…<b>2C</b> shows results for six patients demonstrating decreased viability after administration of IFN-γ. …”

Summary of study eligibility criteria. by Biban Gill (1473337)

“…Considering the high prevalence of BV among African, Caribbean and Black (ACB) women, we conducted a prospective, randomized, open-label phase 1 clinical trial to determine the feasibility, safety and tolerability of administering low-dose estrogen, probiotics or both in combination to improve vaginal health and decrease HIV-1 susceptibility.</p><p>Methods</p><p>ACB women aged 18–49 from the Greater Toronto Area (GTA) were randomized to one of four study arms: intravaginal estradiol (Estring©; 7.5mg/day); a vaginal probiotic (RepHresh™ Pro-B™) administered twice daily; a combination of Estring© and vaginal RepHresh™ Pro-B™ (twice daily); or the Estring© and oral RepHresh™ Pro-B™ (twice daily), for a duration of 30 days. …”

Summary of study participation and feasibility. by Biban Gill (1473337)

“…Considering the high prevalence of BV among African, Caribbean and Black (ACB) women, we conducted a prospective, randomized, open-label phase 1 clinical trial to determine the feasibility, safety and tolerability of administering low-dose estrogen, probiotics or both in combination to improve vaginal health and decrease HIV-1 susceptibility.</p><p>Methods</p><p>ACB women aged 18–49 from the Greater Toronto Area (GTA) were randomized to one of four study arms: intravaginal estradiol (Estring©; 7.5mg/day); a vaginal probiotic (RepHresh™ Pro-B™) administered twice daily; a combination of Estring© and vaginal RepHresh™ Pro-B™ (twice daily); or the Estring© and oral RepHresh™ Pro-B™ (twice daily), for a duration of 30 days. …”

Effect of sample size on reproducibility. by Jan Willem Koten (17743224)

Subjects:

Single ecosystem function-diversity relationships in the mineral soil. by Melissa S. Shinfuku (19942206)

Subjects:

Age-adjusted incidence rate of gastric cancer over 2000–2019 and in 2020 in the United States, by histologic type. by Armin Aslani (13009188)

Subjects:

Effect of corrections on connectivity maps. by Jan Willem Koten (17743224)

Subjects:

Percent change in age-standardized and delay-adjusted incidence rates of gastric cancer from 2019 to 2020, by age, race and sex in the United States, using the November 2022 data s... by Armin Aslani (13009188)

Subjects:

Counts and age-standardized rate of carcinoid tumor incidence per 100,000 and average annual percent change from 2000 to 2019 in the United States, by age, sex, and race. by Armin Aslani (13009188)

Subjects:

Ecosystem multifunctionality bacterial diversity (Shannon H and Pielou J) relationship. by Melissa S. Shinfuku (19942206)

Subjects: